SIRS-Lab GmbH Completes Enrollment in Clinical Trial to Evaluate Pathogen Detection Test VYOO® for Patients with Suspected Sepsis
8/14/2012 9:45:41 AM
More...
|
First Patient Included in Multicenter Study to Evaluate SIRS-Lab GmbH's Diagnostic Test for Blood-Stream Infection
3/22/2011 10:17:56 AM
More...
|
SIRS-Lab GmbH and Analytik Jena Cooperate on Sepsis Diagnostics
6/15/2010 7:02:20 AM
More...
|
Board Elects New CEO to Molecular Diagnostics Company SIRS-Lab GmbH
8/5/2009 6:47:00 AM
More...
|
SIRS-Lab GmbH CEO Dr Stefan Russwurm Asked To Step Down
3/17/2009 1:27:47 PM
More...
|
SIRS-Lab GmbH Reports Growth and Gives Outlook For 2009
3/12/2009 11:09:59 AM
More...
|
SIRS-Lab GmbH Appoints Ed Currie as Executive Vice-President, Corporate Development
2/4/2009 9:52:32 AM
More...
|
SIRS-Lab GmbH Appoints Ania Mitan as Executive VP Commercial Expanding its Senior Management to Further Accelerate the Commercialization of its Unique Sepsis Diagnostics Suite
12/11/2008 9:21:47 AM
More...
|
SIRS-Lab GmbH Receives CE Approval for Sepsis Test "VYOO" and Unfolds Full Clinical Potential
12/3/2008 7:40:22 AM
More...
|
SIRS-Lab GmbH Receives ISO Certification for Molecular in-vitro Sepsis Diagnostics
10/16/2008 11:51:50 AM
More...
|
|